首页> 外文期刊>British Journal of Haematology >Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis.
【24h】

Age-associated difference in gene expression of paediatric acute myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its correlation with prognosis.

机译:小儿急性骨髓单核细胞系白血病(FAB M4和M5亚型)基因表达的年龄相关差异及其与预后的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute myeloid leukaemia, French-American-British M4 and M5 subtypes (AML-M4/M5) is frequently associated with MLL gene rearrangement and its incidence is relatively high among infants. Clinically, paediatric AML-M4/M5 has been considered as an intermediate or undefined prognostic group. In this study, we analysed gene expression of 40 paediatric AML-M4/M5 patients excluding inv(16) and t(8;21) patients, and found striking differences among the patients in an age-associated manner. In particular, most of the infants displayed very distinct gene expression. On the basis of this difference, we divided paediatric patients into three subgroups (A, B and C) with the average age of 0.3, 3.1 and 6.6 years old respectively. All subgroups included patients with MLL gene rearrangement as well as normal and other karyotypes. Surprisingly, gene expression signatures of MLL gene rearrangement differed substantially among these subgroups. In addition, subgroup C presented extremely poor outcome (3-year event-free survival 28%) whilst eight patients with MLL gene rearrangement in subgroup C had all relapsed within 18 months. These results suggest that age is an important factor contributing to the biology of AML-M4/M5 and the sub-grouping procedures developed in this study could be a powerful tool to identify unfavourable risk patients within paediatric AML-M4/M5.
机译:急性髓细胞性白血病,法裔-美式英国M4和M5亚型(AML-M4 / M5)经常与MLL基因重排有关,其发病率在婴儿中相对较高。临床上,小儿AML-M4 / M5被认为是中间或不确定的预后组。在这项研究中,我们分析了40名儿科AML-M4 / M5患者(不包括inv(16)和t(8; 21)患者)的基因表达,并发现他们之间的年龄差异显着。特别是,大多数婴儿表现出非常不同的基因表达。基于此差异,我们将儿科患者分为三个亚组(A,B和C),分别为0.3、3.1和6.6岁。所有亚组均包括MLL基因重排以及正常和其他核型的患者。出乎意料的是,这些亚组之间的MLL基因重排的基因表达特征显着不同。此外,C组的预后极差(3年无事件生存率28%),而C组中8例MLL基因重排的患者在18个月内全部复发。这些结果表明,年龄是影响AML-M4 / M5生物学的重要因素,本研究开发的分组程序可能是确定小儿AML-M4 / M5内不良风险患者的有力工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号